SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-022769
Filing Date
2020-08-19
Accepted
2020-08-19 08:37:14
Documents
4
Period of Report
2020-08-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea125447-8k_inmune.htm 8-K 24123
2 AMENDMENT NO. 1 TO AT-THE-MARKET SALES AGREEMENT, DATED APRIL 16, 2020, BETWEEN ea125447ex1-1_inmune.htm EX-1.1 28856
3 OPINION OF SICHENZIA ROSS FERENCE LLP ea125447ex5-1_inmune.htm EX-5.1 17225
4 GRAPHIC ex5-1_001.jpg GRAPHIC 5498
  Complete submission text file 0001213900-20-022769.txt   79059
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 201115388
SIC: 2836 Biological Products, (No Diagnostic Substances)